Exencial Wealth Advisors’s Opko Health OPK Stock Holding History

Exencial Wealth Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-22,000	Closed	-$205K	–	164
2016 Q4	$205K	Buy	22,000 +2,000	+10%	+$20.7K	0.09%	157
2016 Q3	$188K	Buy	+20,000	New	+$199K	0.08%	159

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Exencial Wealth Advisors's OPK Position: Q1 2017 in Review

Exencial Wealth Advisors sold out of Opko Health (OPK) in Q1 2017, closing a stake of 22,000 shares — an estimated $205K sold.

Exencial Wealth Advisors first reported a position in OPK in Q3 2016 and held it in 2 quarters. The position peaked at $205K in Q4 2016. 245 funds tracked by Wall St. Rank hold OPK as of Q1 2017.

Exencial Wealth Advisors reported no remaining Opko Health position as of Q1 2017 after selling out during the quarter.
Exencial Wealth Advisors sold 22,000 Opko Health shares in Q1 2017, an estimated $205K.
Exencial Wealth Advisors first reported a position in Opko Health in Q3 2016 and held it in 2 quarters.
Exencial Wealth Advisors's Opko Health position peaked at $205K in Q4 2016.
245 funds tracked by Wall St. Rank held Opko Health as of Q1 2017.

Based on Exencial Wealth Advisors's 13F filing for Q1 2017, filed 26 Apr 2017.